(Q24243914)

Francisco Espinosa-Rosales

3

0 references

object named as

Francisco J Espinosa-Rosales

2

0 references

author name string

Blanca Estela Del-Rio-Navarro

1

0 references

Juan JL Sienra-Monge

Cochrane Database of Systematic Reviews

4

0 references

publication date

18 October 2006

0 references

published in

0 references

cites work

Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Levamisole (R 12564) in the prevention of recurrent upper respiratory tract infections in children: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Use of OM-85 BV in children suffering from recurrent respiratory tract infections and subnormal IgG subclass levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

A Placebo Controlled, Double-Blind Evaluation of Levamisole in the Reduction of the Frequency, Duration and Severity of Attacks in Children Suffering from Recurrent Upper Respiratory Tract Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Recurrent respiratory infections in childhood: experience with a bacterial extract plus bacterial ribosomes (Immucytal).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Ribosomal immunostimulation: assessment of studies evaluating its clinical relevance in the prevention of upper and lower respiratory tract infections in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Meta-analysis of published clinical trials of a ribosomal vaccine (ribomunyl) in prevention of respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Primary prevention of acute respiratory tract infections in children using a bacterial immunostimulant: a double-masked, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

A preventive measure for otitis media in children with upper respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Ribosomal therapy in the prophylaxis of recurrent pharyngotonsillitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Short ribosomal prophylaxis in the prevention of clinical recurrences of chronic otitis media in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract: a double-blind, placebo-controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Echinacea purpurea for prevention of upper respiratory tract infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Levamisole in prevention of recurrent upper-respiratory-tract infections in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

A double-blind pediatric evaluation of levamisole in the prevention of recurrent upper respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Quercetin supplementation and upper respiratory tract infection: A randomized community clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Hyposensitization with bacterial vaccine in infectious asthma. A double-blind study and a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Efficacy of an extract of North American ginseng containing poly-furanosyl-pyranosyl-saccharides for preventing upper respiratory tract infections: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Efficacy of a polyvalent bacterial lysate in children with recurrent respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Self treatment with one of three self selected, ultramolecular homeopathic medicines for the prevention of upper respiratory tract infections in children. A double-blind randomized placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Role of zinc administration in prevention of childhood diarrhea and respiratory illnesses: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Effect of vitamin A supplementation on diarrhoea and acute lower-respiratory-tract infections in young children in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Use of Broncho-Vaxom in private practice: phase IV trial in 587 children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Acute respiratory infection: a global challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Vitamin A for preventing acute lower respiratory tract infections in children up to seven years of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Effectiveness of thymostimulin and study of lymphocyte-dependent antibacterial activity in children with recurrent respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

The economic burden of non-influenza-related viral respiratory tract infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

History of respiratory infections in the first 12 yr among children from a birth cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Respiratory viral infection predisposing for bacterial disease: a concise review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Intranasally administered immunoglobulin for the prevention of rhinitis in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Vitamin C intake and susceptibility to the common cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Vitamin C for preventing and treating the common cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Phylogenetic perspectives in innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Effect of pneumococcal conjugate vaccine on pneumococcal meningitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Continued impact of pneumococcal conjugate vaccine on carriage in young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

WITHDRAWN: Antivirals for the common cold

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

CpG motifs: the active ingredient in bacterial extracts?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Selected nonvaccine interventions to prevent infectious acute respiratory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Estimation of the treatment effect in a clinical trial when recurrent events define the endpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

The impact of the pneumococcal conjugate vaccine on antimicrobial resistance in the United States since 1996: evidence for a significant rebound by 2007 in many classes of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

The annual impact of seasonal influenza in the US: Measuring disease burden and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Acute respiratory illness in the community. Frequency of illness and the agents involved

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Epidemiology of viral respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Persistence of upper respiratory tract infections in a cohort followed from childhood to adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Zinc supplementation reduces the incidence of acute lower respiratory infections in infants and preschool children: a double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Toll-like receptors; their physiological role and signal transduction system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Estimates of world-wide distribution of child deaths from acute respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Lack of herbal supplement characterization in published randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Breast feeding and lower respiratory tract illness in the first year of life. Group Health Medical Associates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Clinical and MRI characteristics of levamisole-induced leukoencephalopathy in 16 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

A Novel Use of Xylitol Sugar in Preventing Acute Otitis Media

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Ribosomal therapy in the treatment of recurrent acute adenoiditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

BACTERIAL VACCINE AND INFECTIOUS ASTHMA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Isoprinosine does not protect against frequent respiratory tract infections in childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Clinical and immunobiological effects of an orally administered bacterial extract

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Polybacterial immunomodulator Respivax restores the inductive function of innate immunity in patients with recurrent respiratory infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

The immunostimulant OM-85 BV prevents wheezing attacks in preschool children

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Effects of passive smoking on respiratory illness from birth to age eighteen months, in Shanghai, People's Republic of China

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Public health considerations of infectious diseases in child day care centers. The Child Day Care Infectious Disease Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

The day care center as a risk factor for acute respiratory infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Toll-like receptors control activation of adaptive immune responses

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

A Longitudinal Study of Respiratory Viruses and Bacteria in the Etiology of Acute Otitis Media with Effusion

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Prevalence of Various Respiratory Viruses in the Middle Ear during Acute Otitis Media

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Coordinated Data Group of BOSTID Researchers.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Acute respiratory infections in day care

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. The Epicrèche Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

A prospective, double-blind, placebo-controlled trial of i.v. immunoglobulin and trimethoprim-sulfamethoxazole in children with recurrent respiratory tract infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Immunotherapy with an oral bacterial extract (OM-85 BV) for upper respiratory infections

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Epidemiology of viral infections and evaluation of the potential benefit of OM-85 BV on the virologic status of children attending day-care centers

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Broncho-Vaxom in children with rhinosinusitis: a double-blind clinical trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Pidotimod in the prophylaxis of recurrent acute tonsillitis in childhood

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Illness associated with child day care: a study of incidence and cost

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021

Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004974.PUB2

7 January 2021